Atea Pharmaceuticals plans to launch two parallel Phase 3 trials soon to test its investigational combination therapy of bemnifosbuvir…
Articles by Marisa Wexler, MS
Long-term treatment with Rezdiffra (resmetirom) reduces liver scarring for most people with compensated cirrhosis, or irreversible scarring in a…
A team of experts in the U.S. and Canada have developed patient identification guidelines to help pediatric primary care providers,…
D&D Pharmatech has finished enrolling a Phase 2 clinical trial of its experimental therapy DD01 in overweight or obese…
Four weeks of treatment with vancomycin, a common antibiotic, lowered inflammatory bowel disease (IBD) in people with primary sclerosing…
Long-term exposure to air pollution from traffic, even at relatively low concentrations, may increase the risk of fatty liver…
Children with biliary atresia who have higher blood levels of the matrix metalloproteinase 7 (MMP-7) and alkaline phosphatase (ALP)…
A virtual clinic for liver diseases, including hepatitis, has begun treating patients. The LiverRight Hepatology Clinic offers same-week…
Treatment with Livmarli (maralixibat) is effective for relieving itch in adolescents with Alagille syndrome, according to a new…
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to brelovitug, a hepatitis D treatment that’s…